高级检索
当前位置: 首页 > 详情页

Association between nonalcoholic fatty liver and increased low-level albuminuria in postmenopausal women in China: A cross-sectional study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]School of Medicine, Nankai University, Tianjin, China [2]Department of Endocrinology, Chinese People's Liberation Army General Hospital, Beijing, China [3]Department of Nutrition, Beijing Friendship Hospital, Capital Medical University, Beijing, China [4]Department of Endocrinology, The First Hospital of Lanzhou University, Lanz7hou, Gansu, China. Department of Endocrinology, Center Hospital of Dalian, Dalian, China [5]Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China [6]Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China [7]Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [8]Department of Endocrinology, Union Hospital, Tongji Medical College, Wuhan, China [9]Department of Endocrinology, Shanghai National Research Center for Endocrine and Metabolic Disease, State Key Laboratory of Medical Genomics, Shanghai Institute for Endocrine and Metabolic Disease, Ruijin Hospital. Shanghai Jiaotong University School of Medicine, Shanghai, China
出处:
ISSN:

关键词: low‐ level albuminuria nonalcoholic fatty liver disease nonalcoholic steatohepatitis urinary albumin to creatinine ratio

摘要:
Background Several studies have suggested that nonalcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease (CVD). The excretion of low-level albuminuria (LLA) elevates as the prevalence of CVD increases. However, few studies have explored the association between NAFLD and LLA. Methods This cross-sectional study included 31 147 Chinese adults (7664 men and 23 483 women). The "normal" level of albuminuria as determined by the urinary albumin to creatinine ratio (UACR) was below 30 mg/g. LLA was defined as a higher level within the "normal" albuminuria range (5.54 mg/g < LLA <= 29.9 mg/g). The participants with NAFLD were defined as having a fatty liver index (FLI) >= 60. The FLI was calculated using the Bedogni equation. Results A positive association was found between UACR and FLI through multivariate linear regression analyses (nonstandardized beta +/- SE: .047 +/- 0.004, P <.001). The logistic regression analyses revealed that NAFLD had adjusted odds ratios (ORs) showing a significant relationship with LLA in models 1 to 4 (all subjects: OR, 1.207; 95% CI, 1.098-1.326; women: OR, 1.43; 95% CI, 1.26-1.63; all P <.001); however, we did not find significant adjusted ORs among the men. In the stratified analyses, the relationship between NAFLD and LLA was significant among postmenopausal women with a body mass index >= 24 but <28 kg/m(2), fasting plasma glucose >= 5.6 but <7.0 mmol/L, or postprandial plasma glucose >= 7.8 but <11.1 mmol/L and those aged below 60 years without moderate-intensity exercise. Conclusions A noteworthy association between NAFLD and LLA was found among postmenopausal women who had borderline blood glucose values, were overweight, and did not engage in moderate-intensity physical activity.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢
JCR分区:
出版当年[2019]版:
Q2 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2019版] 出版当年五年平均[2015-2019] 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]School of Medicine, Nankai University, Tianjin, China [2]Department of Endocrinology, Chinese People's Liberation Army General Hospital, Beijing, China
通讯作者:
通讯机构: [1]School of Medicine, Nankai University, Tianjin, China [2]Department of Endocrinology, Chinese People's Liberation Army General Hospital, Beijing, China [*1]Department of Endocrinology, Chinese People's Liberation Army General Hospital, No. 28 Fuxing Road, Beijing 100853, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)